Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Rev Clin Esp (Barc) ; 223(4): 193-201, 2023 04.
Artigo em Inglês | MEDLINE | ID: mdl-36842660

RESUMO

BACKGROUND: Chagas disease (CD) is a parasitic disease caused by Trypanosoma cruzi, in which up to 10-20% of those affected may suffer digestive disorders. Multiple studies have been carried out on CD in non-endemic countries, mainly related to cardiological involvement. However, digestive disorders have not been analyzed in such depth. The objective of the study was to determine the prevalence of digestive disorders in imported CD at the time of first care. METHODS: An observational cross-sectional descriptive analysis of imported CD was performed. Chagasic structural damage and infectious digestive comorbidity were evaluated. The association between Chagasic structural damage and heart disease in Chagas patients was also investigated. RESULTS: After reviewing a total of 1,216 medical records, those of 464 patients were selected for analysis. Globally, the prevalence of digestive disorders in imported Chagas was 57.76%, 95% CI (53.25-62.27). The prevalence of comorbidity of infectious diseases was 40.73% CI 95% (36.25-45.22). Colonic abnormalities were found in 84 of 378 barium enema patients. CD-related esophageal abnormalities were present in 63 of 380 patients studied with esophagogram. CONCLUSIONS: The prevalence of digestive disorders associated with CD is high, so the presence of infectious diseases (mainly parasitic and H. pylori infection) should be ruled out. It is important to exclude structural involvement in all symptomatic patients, and asymptomatic patients should also be considered and offered.


Assuntos
Doença de Chagas , Doenças do Sistema Digestório , Trypanosoma cruzi , Humanos , Prevalência , Estudos Transversais , Doença de Chagas/complicações , Doença de Chagas/epidemiologia , Doença de Chagas/parasitologia , Doenças do Sistema Digestório/etiologia , Doenças do Sistema Digestório/complicações
2.
Clin Nutr ; 40(6): 4449-4455, 2021 06.
Artigo em Inglês | MEDLINE | ID: mdl-33509666

RESUMO

BACKGROUND & AIMS: Malnutrition is prevalent in upper gastrointestinal cancer patients. The purpose of this study was a comprehensive assessment of nutritional status in newly diagnosed patients with esophageal cancer. METHODS: Newly diagnosed esophageal cancer patients were referred to a chemo-radiation referral center in Mashhad, Iran, between February 2017 to February 2019. Anthropometric indices, a Patient-Generated Subjective Global Assessment (PG-SGA) tool, body composition, dietary intake, nutritional-related complications, and laboratory tests were assessed. RESULTS: One hundred and eighty-nine patients with a mean age of 67.1 ± 12 and a male to female ratio of 98 to 91 were included. Ninety-seven (51.3%) of patients had experienced significant weight loss and 56 (29.6%) were underweight at diagnosis. According to PG-SGA, 179 (94.7%) needed nutritional interventions. Reduced muscle mass and low handgrip strength were observed in 70 (39.4%) and 26 (14.4%) of patients, respectively. Inadequate intakes of energy (less than 24 kcal/kg/day) and protein (less than 1.2 g/kg/day) were found in 146 (77.8%) and 171 (91%) patients, respectively. The mean total daily energy and protein intakes of subjects were 943.8 ± 540 kcal/day, and 30.6 ± 21 g/day, respectively. The most common nutritional-related complications were as follows: dysphagia (84.8%), anorexia (31.6%), constipation (62.1%), esophageal pain (48.4%), and dyspepsia (41.1%). CONCLUSION: Our study demonstrated a high prevalence of malnutrition in newly diagnosed esophageal cancer patients. This fact demonstrates the importance of early screening of nutritional status via PG-SGA tool, clinical evaluation, dietary intake evaluations, and laboratory tests, based on which effective nutritional interventions and Symptoms management may be introduced in these patients.


Assuntos
Doenças do Sistema Digestório/complicações , Neoplasias Esofágicas/complicações , Neoplasias Esofágicas/fisiopatologia , Desnutrição/complicações , Estado Nutricional , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos Transversais , Proteínas Alimentares/administração & dosagem , Ingestão de Energia , Neoplasias Esofágicas/diagnóstico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Terapia Nutricional , Prevalência , Classe Social , Redução de Peso
3.
Chirurg ; 81(11): 1013-9, 2010 Nov.
Artigo em Alemão | MEDLINE | ID: mdl-20464353

RESUMO

BACKGROUND: In view of the threat that comes with an acute abdomen, it is of major importance that diagnostics are executed quickly and efficiently. In the course of this two tendencies can be differentiated: 1) general use of complex examination (e.g. CT, MRT) of all potential patients and 2) step-by-step-diagnostics with advanced diagnostics as and when required. MATERIAL AND METHODS: A total of 444 patients with an acute abdomen as admission diagnosis were investigated. All data were evaluated prospectively and analyzed retrospectively. All patients had the same basic diagnostics consisting of aclinical history, clinical examination, laboratory examination, abdominal sonography and x-ray overview images. These examinations were supplemented when required by advanced measures, such as CT, colon enema with contrast fluid, endoscopic examination and diagnostic laparotomy. RESULTS: Three different disease groups of unequal diagnostic need could be identified. The first group, presented in the form of an appendicitis showed that in 80% of all patients a basic diagnosis was sufficient. Advanced examination such as CT affected 14%. The negative appendectomy rate amounted to 8%. Other diseases belonging to the first group were ileus, acute biliary diseases, perforation etc. In the second group presented in the form of a diverticulitis, an advanced radiological examination was required in 84% of all cases. Similar results are also expected in cases of pancreatitis. In the third group presented in the form of coprostasis, inflammatory etiology was found in 39% of all secondary diseases. However the symptoms became clinically apparent after treatment of the coprostasis. In this group a basic diagnosis was satisfactory in 84% of cases, however, a diagnostic laparotomy was inevitable for 3% of these patients. CONCLUSION: Generally step-by-step diagnostic approach has proven itself to be efficient. For 80% of all patients it makes advanced diagnostic measures unnecessary. The exceptions are diseases in which it is necessary to know not only the diagnosis but also the disease stage. In these cases (e.g. pancreatitis, diverticulitis etc.) advanced diagnostics should be pursued from the onset. The necessity of a diagnostic laparotomy has lost importance for 1% of all patients.


Assuntos
Abdome Agudo/etiologia , Doenças do Sistema Digestório/complicações , Doenças do Sistema Digestório/diagnóstico , Abdome Agudo/diagnóstico , Abdome Agudo/cirurgia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Apendicite/complicações , Apendicite/diagnóstico , Colecistite/complicações , Colecistite/diagnóstico , Diagnóstico Diferencial , Doença Diverticular do Colo/complicações , Doença Diverticular do Colo/diagnóstico , Impacção Fecal/complicações , Impacção Fecal/diagnóstico , Feminino , Alemanha , Hospitais Universitários , Humanos , Íleus/complicações , Íleus/diagnóstico , Isquemia/complicações , Isquemia/diagnóstico , Imageamento por Ressonância Magnética , Masculino , Mesentério/irrigação sanguínea , Pessoa de Meia-Idade , Tomografia Computadorizada por Raios X , Adulto Jovem
5.
Pediatr Clin North Am ; 56(5): 1185-200, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19931070

RESUMO

Intestinal failure (IF) is the ultimate malabsorption state, with multiple causes, requiring long-term therapy with enteral or intravenous fluids and nutrient supplements. The primary goal during management of children with potentially reversible IF is to promote intestinal autonomy while supporting normal growth, nutrient status, and preventing complications from parenteral nutrition therapy. This article presents how an improved understanding of digestive pathophysiology is essential for diagnosis, successful management, and prevention of nutrient deficiencies in children with IF.


Assuntos
Doenças do Sistema Digestório/fisiopatologia , Absorção Intestinal , Síndromes de Malabsorção/complicações , Síndromes de Malabsorção/fisiopatologia , Desnutrição/etiologia , Desnutrição/fisiopatologia , Micronutrientes , Criança , Pré-Escolar , Doenças do Sistema Digestório/complicações , Gastroenteropatias/complicações , Gastroenteropatias/fisiopatologia , Humanos , Lactente , Síndromes de Malabsorção/metabolismo , Desnutrição/metabolismo , Micronutrientes/administração & dosagem , Micronutrientes/deficiência , Micronutrientes/metabolismo , Nutrição Parenteral/efeitos adversos , Síndrome do Intestino Curto/complicações , Síndrome do Intestino Curto/fisiopatologia , Oligoelementos/administração & dosagem , Oligoelementos/deficiência , Oligoelementos/metabolismo , Vitaminas/administração & dosagem , Vitaminas/metabolismo
6.
World J Gastroenterol ; 15(37): 4686-94, 2009 Oct 07.
Artigo em Inglês | MEDLINE | ID: mdl-19787832

RESUMO

Allogeneic blood transfusion (ABT) is frequently used as the first therapeutic option for the treatment of acute anaemia in patients with inflammatory bowel disease (IBD), especially when it developed due to gastrointestinal or perioperative blood loss, but is not risk-free. Adverse effects of ABT include, but are not limited to, acute hemolytic reaction (wrong blood or wrong patient), febrile non-hemolytic transfusional reaction, bacterial contamination, transfusion-related acute lung injury, transfusion associated circulatory overload, transfusion-related immuno-modulation, and transmission of almost all infectious diseases (bacteria, virus, protozoa and prion), which might result in increased risk of morbidity and mortality. Unfortunately, the main physiological goal of ABT, i.e. to increase oxygen consumption by the hypoxic tissues, has not been well documented. In contrast, the ABT is usually misused only to increase the haemoglobin level within a fixed protocol [mostly two by two packed red blood cell (PRC) units] independently of the patient's tolerance to normovolemic anaemia or his clinical response to the transfusion of PRC units according to a "one-by-one" administration schedule. Evidence-based clinical guidelines may promote best transfusion practices by implementing restrictive transfusion protocols, thus reducing variability and minimizing the avoidable risks of transfusion, and the use of autologous blood and pharmacologic alternatives. In this regard, preoperative autologous blood donation (PABD) consistently diminished the frequency of ABT, although its contribution to ABT avoidance is reduced when performed under a transfusion protocol. In addition, interpretation of utility of PABD in surgical IBD patients is hampered by scarcity of published data. However, the role of autologous red blood cells as drug carriers is promising. Finally, it must be stressed that a combination of methods used within well-constructed protocols will offer better prospects for blood conservation in selected IBD patients undergoing elective surgery.


Assuntos
Anemia/terapia , Transfusão de Sangue/métodos , Doenças do Sistema Digestório/complicações , Doenças Inflamatórias Intestinais/complicações , Doença Aguda , Anemia/etiologia , Transfusão de Sangue Autóloga/efeitos adversos , Transfusão de Sangue Autóloga/métodos , Colite Ulcerativa/complicações , Doença de Crohn/complicações , Humanos , Cuidados Pré-Operatórios , Reação Transfusional , Resultado do Tratamento
7.
Infez Med ; 16 Suppl 1: 57-62, 2008 Feb.
Artigo em Italiano | MEDLINE | ID: mdl-18382152

RESUMO

Antimicrobial therapy of intra-abdominal infection should consider its aetiology, which is generally polymicrobial, and its location with the aim of selecting the most suitable antimicrobial agents not only according to its spectrum but also to its pharmacokinetics profile Currently, both monotherapy and association therapy can be used, thanks the availability of newer drugs characterized by a wide range of antimicrobial activity both against aerobes and anaerobes. Antibiotic choice and duration therapy vary also according to the infection severity .


Assuntos
Cavidade Abdominal , Antibacterianos/uso terapêutico , Doenças do Sistema Digestório/tratamento farmacológico , Doenças do Sistema Digestório/microbiologia , Antibacterianos/farmacocinética , Antibacterianos/farmacologia , Doenças do Sistema Digestório/complicações , Humanos , Testes de Sensibilidade Microbiana , Guias de Prática Clínica como Assunto
8.
Curr Opin Gastroenterol ; 24(2): 176-83, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18301268

RESUMO

PURPOSE OF REVIEW: The purpose of this review is to report on the vitamin D status and its relationship with bone health in individuals with gastrointestinal and liver disorders. In addition, recommendations regarding replacement and maintenance of optimal vitamin D stores, as well as the state of knowledge regarding its effect on the disease through its actions on the immune system, will be reviewed. RECENT FINDINGS: The scientific community has revised upward the serum levels of vitamin D considered optimal, and doses of vitamin D much larger than those currently recommended may be needed to maintain these levels, especially in individuals with gastrointestinal and liver disorders. The relationship between vitamin D and bone health in this population is controversial. The role of vitamin D in the regulation of the immune system continues to be elucidated. SUMMARY: Hypovitaminosis D is prevalent among individuals with gastrointestinal and liver disease. Although replacement and supplementation guidelines have not been well defined, practitioners should aim for a serum 25-hydroxyvitamin D level of at least 32 ng/ml. The contribution of vitamin D to the bone health of these individuals and its role in altering disease course through its actions on the immune system remain to be elucidated.


Assuntos
Doenças do Sistema Digestório/complicações , Deficiência de Vitamina D , Vitamina D/fisiologia , Doenças Ósseas/etiologia , Doenças Ósseas/prevenção & controle , Gastroenteropatias/complicações , Humanos , Sistema Imunitário/efeitos dos fármacos , Doenças do Sistema Imunitário/etiologia , Hepatopatias/complicações , Vitamina D/administração & dosagem , Vitamina D/análogos & derivados , Vitamina D/sangue , Deficiência de Vitamina D/sangue , Deficiência de Vitamina D/tratamento farmacológico , Deficiência de Vitamina D/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA